Back to Search
Start Over
Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects.
- Source :
-
Journal of Experimental & Clinical Cancer Research (17569966) . 1/27/2022, Vol. 41 Issue 1, p1-6. 6p. - Publication Year :
- 2022
-
Abstract
- An amendment to this paper has been published and can be accessed via the original article. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 17569966
- Volume :
- 41
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Journal of Experimental & Clinical Cancer Research (17569966)
- Publication Type :
- Academic Journal
- Accession number :
- 154921944
- Full Text :
- https://doi.org/10.1186/s13046-022-02247-y